Jeanette Marchant reports on discussions at the US Food and Drug Administration public hearing on how drug and medical device companies should use the internet and social media to promote regulated products.
At a packed public hearing on 12-13 November, the US Food and Drug Administration heard from around 70 speakers on how the agency should be regulating internet and social media promotion of medical products1,2...
Please login to read the full article.
